grant

The role for cell cycle regulators in trichloroethylene induced Parkinson's dementia

Organization UNIVERSITY OF ALABAMA AT BIRMINGHAMLocation BIRMINGHAM, UNITED STATESPosted 1 Aug 2024Deadline 31 Jul 2027
NIHUS FederalResearch GrantFY202521+ years oldAbscissionAdultAdult HumanAgingAirAmentiaAmmon HornAreaAstrocytesAstrocytusAstrogliaAutomobile DrivingAutopsyBrainBrain Nervous SystemBrain regionC57BL/6 MouseCDK4ICDK5CDK5 geneCDKN2CDKN2 GenesCDKN2ACDKN2A geneCMM2Cell AgingCell CycleCell Cycle ProteinsCell Division CycleCell Division Cycle ProteinsCell Division Kinase 5Cell Division Kinase 5 GeneCell Division Protein Kinase 5Cell SenescenceCell-Cycle Regulatory ProteinsCellular AgingCellular SenescenceCognitionCognitiveCognitive DisturbanceCognitive ImpairmentCognitive ManifestationsCognitive SymptomsCognitive declineCognitive deficitsCognitive function abnormalCommunicationCornu AmmonisCyclin-Dependent Kinase 5Cyclin-Dependent Kinase Inhibitor 2A GeneDA NeuronDataDegenerative Neurologic DisordersDementiaDentate FasciaDevelopment and ResearchDiseaseDisease ProgressionDisorderDisturbance in cognitionDopamine neuronDyskinesia SyndromesEducational process of instructingEncephalonEnvironmentEnvironmental ExposureEnvironmental PollutantsEnvironmental ToxinEpidemiologyEthicsEthinyl TrichlorideExcisionExposure toExtirpationFascia DentataFosteringFoundationsGanciclovirGancyclovirGenetic predisposing factorGliaGlial CellsGoalsGyrus DentatusHeterogeneityHippocampusHydrogen OxideINK4INK4AImpaired cognitionImpairmentInhalationInhalingInvestigatorsKinasesKolliker's reticulumLB pathologyLearningLewy body pathologyLewy pathologyLinkMTS1MTS1 GenesMeasuresMediatingMemoryMentorsMentorshipMiceMice MammalsModelingMovement Disorder SyndromesMovement DisordersMurineMusNAC precursorNational Institutes of HealthNerve CellsNerve DegenerationNerve UnitNervous System Degenerative DiseasesNeural CellNeural Degenerative DiseasesNeural Stem CellNeural degenerative DisordersNeurobehavioral ManifestationsNeurobehavioral Signs and SymptomsNeurocyteNeurodegenerative DiseasesNeurodegenerative DisordersNeurogliaNeuroglial CellsNeurologic Degenerative ConditionsNeuron DegenerationNeuronsNon-neuronal cellNonneuronal cellNordeoxyguanosineOrganic SolventsOrganic solvent productPARK1 proteinPARK4 proteinPD with dementiaParalysis AgitansParkinsonParkinson DiseaseParkinson Disease dementiaParkinson's DementiaParkinson's disease with dementiaParkinsonianParkinsonian ConditionParkinsonian DiseasesParkinsonian DisordersParkinsonian SyndromeParkinsonismPathogenicityPathologyPathway interactionsPatientsPeptidesPesticidesPhenotypePhosphotransferase GenePhosphotransferasesPopulationPositionPositioning AttributePreparationPrimary ParkinsonismProcessProgenitor CellsProliferatingProteinsR & DR&DRemovalReplicative SenescenceReporterReproducibilityResearchResearch PersonnelResearch ProposalsResearchersResponse ElementsRodentRodentiaRodents MammalsRoleSNCASNCA proteinScienceScientistSerine/Threonine-Protein Kinase PSSALRESeverity of illnessSoilSolventsSurgical RemovalTP16TPKII Catalytic SubunitTSG9ATau Protein Kinase II Catalytic SubunitTeachingTechnical ExpertiseTestingTherapeuticToxic Environmental AgentsToxic Environmental SubstancesTrainingTraining ProgramsTransphosphorylasesTrichloroetheneTrichloroethyleneUnited StatesUnited States National Institutes of HealthViralWaterWorka-syna-synucleinadult neurogenesisadulthoodalpha synucleinalpha synuclein genealphaSP22astrocytic gliaasynbrain tissueburden of diseaseburden of illnesscareercareer developmentcdc Proteinscdc2-related kinase PSSALREcognitive decline in Parkinson'scognitive defectscognitive dysfunctioncognitive dysfunction in Parkinson'scognitive impairment in Parkinson'scognitive losscognitive performancedegenerative diseases of motor and sensory neuronsdegenerative neurological diseasesdementia in PDdementia in Parkinson diseasedentate gyrusdisease burdendisease riskdisease severitydisorder riskdopaminergic neurondrivingenvironmental contaminantenvironmental toxicantepidemiologicepidemiologicalethicalexperiencegenetic risk factorhippocampalhyper-phosphorylated tauhyperphosphorylated tauimprovedinherited factorknock-downknockdownmotor deficitnecropsynerve cell deathnerve cell lossnerve cementnerve stem cellneural degenerationneural precursorneural precursor cellneural progenitorneural progenitor cellsneural stem and progenitor cellsneurobehavioral symptomneurodegenerationneurodegenerativeneurodegenerative illnessneurogenesisneurogenic progenitorsneurogenic stem cellneurological degenerationneuron cell deathneuron cell lossneuron deathneuron lossneuron progenitorsneuronalneuronal cell deathneuronal cell lossneuronal deathneuronal degenerationneuronal lossneuronal progenitorneuronal progenitor cellsneuronal stem cellsneuroprogenitorneurotoxicologynon A-beta component of AD amyloidnon A4 component of amyloid precursornovelp-taup-τp14ARFp16 Genesp16INK4 Genesp16INK4A Genesp16INK4apathwayphospho-tauphospho-τphosphorylated taupost-translational modification of taupostmortemposttranslational modification of taupreparationspreventpreventingprogenitor and neural stem cellsprogenitor cell nicheprogenitor cell poolprogenitor cell populationprogenitor cell proliferationprogenitor nicheprogenitor poolprogenitor populationprogenitor proliferationreplicative agingresearch and developmentresectionsenescencesenescentsenescent cellskillssocial rolestem and progenitor cell nichestem and progenitor cell populationstem and progenitor cell proliferationstem cell nichestem cell poolstem cell populationstem cell proliferationstem cellstargeted drug therapytargeted drug treatmentstargeted therapeutictargeted therapeutic agentstargeted therapytargeted treatmenttau dysfunctiontau dysregulationtau phosphorylationtau posttranslational modificationtau-1teachertechnical skillstherapeutic targettoxicanttrichloro-etheneα synuclein geneα-synα-synucleinτ dysfunctionτ phosphorylation
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Project Summary
The purpose of this NIH F31 application is to obtain support for the PI, Ashley Adamson, to carry out mentored

research and career development activities such that the PI obtains the necessary experience and training to

become a rigorous independent researcher. The project goal is to leverage the PI’s current skillset with a rigorous

training program to position her to study the key proteins, pathways, and mechanisms behind environmentally

caused neurodegenerative diseases, namely Parkinson’s disease dementia. The primary objective of this

research proposal is to investigate the role of cell cycle regulatory proteins in facilitating cognitive impairments

caused by trichloroethylene exposure in the context of Parkinson’s disease dementia. Work from the lab of Dr.

Briana De Miranda, the PI’s sponsor, has shown that exposure to trichloroethylene inhalation induces

nigrostriatal dopaminergic neurodegeneration, motor deficits, and alpha-synuclein accumulation in mice.

Furthermore, the PI showed that trichloroethylene exposure induces cognitive deficits congruent with those

commonly observed in Parkinson’s disease. However, it is currently unknown by what mechanisms

trichloroethylene facilitates these deficits. This project aims to increase our understanding of the mechanisms by

which cognitive impairment is induced by trichloroethylene exposure by evaluating the roles of aberrant CDK5

activation in pathogenic protein accumulation (Aim 1) and increased cellular senescence in neural stem cell

populations (Aim 2). The long-term objective of the PI’s research is to identify the role for environmental

exposures in influencing the significant heterogeneity of cognitive symptomology in Parkinson’s disease, and to

identify disease modifying therapeutic strategies to stop the progression of the disease.

The proposed training plan for Ashley Adamson is sponsored by Dr. Briana De Miranda and co-sponsored by

Dr. Erik Roberson. The overall goal of the training plan is to provide Ashley with the conceptual and technical

skills necessary to establish a strong foundation for a career in academic research. The training plan has been

developed with activities to foster Ashley’s training in 3 crucial areas: 1) conceptual and technical research,

including studies in neurodegeneration, cognition, and neurotoxicology; 2) statistical rigor, reproducibility, and

transparency; including preparation in ethical research practices; and 3) career development, including training

in mentorship, teaching, and scientific communication. This proposal will uniquely prepare the PI to conduct

rigorous hypothesis-driven research in neurotoxicology and neurodegenerative disease while also curating the

skills necessary for a becoming a competent scientist, teacher, and mentor in academic science.

Grant Number: 5F31ES036890-02
NIH Institute/Center: NIH

Principal Investigator: Ashley Adamson

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →